Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Association of the Advanced Lung Cancer Inflammation Index (ALI) and Gustave Roussy Immune (GRIm) score with immune checkpoint inhibitor efficacy in patients with gastrointestinal and lung cancer

Fig. 3

(A) Forest plots of the relationship between advanced lung cancer inflammation index and progression-free survival (heterogeneity index I2 = 31.3%, p = 0.189; HR: 0.61, 95% CI: 0.52–0.72, p < 0.001). (B) Sensitivity analysis of the association between advanced lung cancer inflammation index and progression-free survival. HR, hazard ratio; CL, confidence interval

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us